The Medicines Co (NASDAQ:MDCO)
During the Trading Day
| 33.32 |  +0.79 / +2.43% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 33.32 |  0.00 / 0.00% |
Volume: 14.2K |
Latest MDCO News | Press Releases
| Why The Medicines Company May Be About to Take Off May 16 / MotleyFool.com | Pediatric Approval for MDCO/BMY's Recothrom - Analyst Blog May 15 / Zacks.com |
Today’s Trading
| Previous close | 32.53 |
| Today’s open | 31.86 |
| Day’s range | 31.31 - 33.64 |
| Volume | 1,417,841 |
| Average volume (3 months) | 887,406 |
| Market cap | $1.8B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -60.43% |
| Earnings growth (this year) | +5.15% |
| Earnings growth (next 5 years) | +31.50% |
| Revenue growth (last year) | +15.24% |
| P/E ratio | 56.5 |
| Price/Sales | 2.30 |
| Price/Book | 2.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MNKDMannkind Corp | +0.62 | +9.95% |
| ARNAArena Pharmaceutical... | +0.14 | +1.77% |
| VPHMViroPharma Inc | +0.34 | +1.30% |
| QCORQuestcor Pharmaceuti... | -0.72 | -2.00% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.32 |
| Annual revenue (last year) | $558.6M |
| Annual profit (last year) | $51.3M |
| Net profit margin | 9.18% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Clive A. Meanwell, MD, PhD |
President, CFO, Treasurer & Director Glenn P. Sblendorio, MBA |
Corporate headquarters Parsippany, New Jersey |
Forecasts
